Publication | Closed Access

Prognostic value of tumor-infiltrating lymphocytes in patients with early-stage triple-negative breast cancers (TNBC) who did not receive adjuvant chemotherapy

Breast OncologyCancer ImmunosurveillanceMedicinePrognostic ValueImmunologyAdjuvant ChemotherapyPathologyBreast CancerOncologyTumor MicroenvironmentTumor-infiltrating Lymphocytes